Most Read This Week
- Invasive Disease–Free Survival and Brain Metastasis Rates in Patients Treated With Neoadjuvant Chemotherapy With Trastuzumab and Pertuzumab
- Gemcitabine, Cisplatin, and Nab-Paclitaxel vs Gemcitabine and Cisplatin for Newly Diagnosed Advanced Biliary Tract Cancers
- Surgeon General Highlights Link Between Alcohol and Cancer, Urges Warning Labels
- FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
- Patient-Centered Pathology Reports Improve Prostate Cancer Understanding
Recently Updated
- Decrease Seen in In Situ Breast Cancer Since 2009
- Surgeon General Highlights Link Between Alcohol and Cancer, Urges Warning Labels
- Patient-Centered Pathology Reports Improve Prostate Cancer Understanding
- FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
- Association Between JAK2-Mutant Clonal Hematopoiesis of Indeterminate Potential and Venous Thromboembolism Risk